Genetic Stratification: Redefining Market Segmentation in Neurology

Ajouter une nouvelle offre d'emploi Health

2025-12-26 09:24:22 -

Why is traditional broad-spectrum treatment becoming obsolete? Historically, Parkinson’s was treated as a monolithic condition. Modern genomic research has revealed it is a collection of subtypes with varying biological drivers. For biopharma companies, this means the end of the "one size fits all" blockbuster model in neurology. Companies are now segmenting the market based on genetic...

0 Commentaires 0 Parts 5 Vue 0 Aperçu